Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allergic Diseases and Internalizing Behaviors in Early Childhood.
Nanda MK, LeMasters GK, Levin L, Rothenberg ME, Assa'ad AH, Newman N, Bernstein D, Khurana-Hershey G, Lockey JE, Ryan PH. Nanda MK, et al. Pediatrics. 2016 Jan;137(1):e20151922. doi: 10.1542/peds.2015-1922. Epub 2015 Dec 29. Pediatrics. 2016. PMID: 26715608 Free PMC article.
Hypereosinophilic syndromes.
Assa'ad AH, Spicer RL, Nelson DP, Zimmermann N, Rothenberg ME. Assa'ad AH, et al. Chem Immunol. 2000;76:208-29. doi: 10.1159/000058787. Chem Immunol. 2000. PMID: 10761312 Review. No abstract available.
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME. Garrett JK, et al. J Allergy Clin Immunol. 2004 Jan;113(1):115-9. doi: 10.1016/j.jaci.2003.10.049. Epub 2003 Dec 12. J Allergy Clin Immunol. 2004. PMID: 14699394 Clinical Trial.
Anti-IL-5 and hypereosinophilic syndromes.
Sutton SA, Assa'ad AH, Rothenberg ME. Sutton SA, et al. Clin Immunol. 2005 Apr;115(1):51-60. doi: 10.1016/j.clim.2005.02.006. Clin Immunol. 2005. PMID: 15870021 Review.
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.
Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Blanchard C, et al. J Clin Invest. 2006 Feb;116(2):536-47. doi: 10.1172/JCI26679. J Clin Invest. 2006. PMID: 16453027 Free PMC article.
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK, Filipovich AH, Assa'ad AH, Rothenberg ME. Stein ML, et al. J Allergy Clin Immunol. 2006 Dec;118(6):1312-9. doi: 10.1016/j.jaci.2006.09.007. Epub 2006 Nov 7. J Allergy Clin Immunol. 2006. PMID: 17157662 Clinical Trial.
Pediatric patients with eosinophilic esophagitis: an 8-year follow-up.
Assa'ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL, Buckmeier BK, Bullock JZ, Collier AR, Konikoff MR, Noel RJ, Guajardo JR, Rothenberg ME. Assa'ad AH, et al. J Allergy Clin Immunol. 2007 Mar;119(3):731-8. doi: 10.1016/j.jaci.2006.10.044. Epub 2007 Jan 25. J Allergy Clin Immunol. 2007. PMID: 17258309
133 results